Skin & hair

What Actually Repigments Vitiligo Now

Save

For years, vitiligo advice amounted to cover it up and hope. That has changed. Between narrowband light therapy, established creams, a newly approved JAK-inhibitor cream, and surgical options for stubborn stable patches, there is now a real menu — with honest odds attached to each. Here is what repigments skin, how well, and where it works best.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

What vitiligo is, and what treatment means here

Vitiligo is a chronic autoimmune condition in which the immune system attacks and destroys melanocytes — the cells that make skin pigment — leaving smooth, milky-white patches that can appear at any age 1. It is not an infection, it is not contagious, and it does not damage the skin's structure; the color is simply gone. There is no cure, but that is very different from no treatment.

The realistic goals of treatment are two. The first is to stop new patches from forming and existing ones from spreading — to stabilize the condition. The second is to coax pigment back into the white areas — to repigment them 1. Which goal comes first depends on whether the vitiligo is actively moving or holding steady, and a clinician gauges that before choosing a plan. Understanding the vitiligo treatment options starts with knowing that both stabilizing and repigmenting are on the table.

It helps to know vitiligo comes in patterns. The common nonsegmental form appears symmetrically on both sides of the body and tends to be the kind studied in the major trials. A less common segmental form stays on one side and often stabilizes early. And it is worth naming what vitiligo is not: it is a loss of pigment, the mirror image of a condition like melasma, which is an excess of pigment and follows an entirely different melasma treatment plan.

How vitiligo is diagnosed, and what it can be mistaken for

Vitiligo is usually diagnosed by eye. A clinician recognizes the smooth, milky-white, well-defined patches, often symmetrical, and frequently confirms them under a Wood's lamp — an ultraviolet light that makes truly depigmented skin glow and stand out from the surrounding tone, which is especially helpful in fair skin where the patches are subtle. A biopsy is rarely necessary.

Because the treatment and the outlook differ, it matters to separate vitiligo from other conditions that lighten the skin. Tinea versicolor, a common yeast overgrowth, leaves lighter patches that are finely scaly and tend to come and go with heat and humidity. Pityriasis alba causes pale, slightly rough patches on the cheeks of children. Post-inflammatory hypopigmentation is lighter skin left behind after a rash, burn, or injury, and it usually recovers on its own. Each of these is only partly lighter, whereas vitiligo is fully depigmented — a distinction the exam is built to catch.

A clinician also judges whether the vitiligo is active or stable, since a patch with a blurred, advancing border or new confetti-like spots signals ongoing spread, while a sharp, quiet border suggests it has settled. That single judgment — moving or stable — shapes everything that follows, because active disease calls for stabilizing first, and stable disease opens the door to repigmentation and, for the right patches, surgery.

What actually repigments the skin

Two approaches have the strongest evidence for bringing color back, and they are often used together. The first is light-based: narrowband UVB phototherapy produces meaningful repigmentation in vitiligo, with the response building over months of regular sessions rather than appearing quickly 2. For small or isolated patches, a targeted form of light called excimer can treat just the affected skin. Phototherapy has become a backbone of vitiligo care because it works across many body sites. Regular phototherapy does ask for a real time commitment — sessions several times a week over a sustained stretch — which is part of choosing it.

The second is topical anti-inflammatory creams. Long-established options include topical corticosteroids and calcineurin inhibitors such as tacrolimus, which are especially useful on the face. The newer arrival is topical ruxolitinib, a JAK-inhibitor cream: in large phase 3 trials of nonsegmental vitiligo in people aged 12 and older, it produced significantly more facial and overall repigmentation than an inactive vehicle cream 3. Interest in ruxolitinib for vitiligo has been high precisely because it is a targeted, approved option rather than an off-label borrow.

JAK inhibitors are part of a broader shift. The same class is now central to alopecia areata treatment and is being studied as an oral therapy for more widespread vitiligo. What ties these newer options together is that they aim at the specific immune signaling behind the pigment loss, rather than broadly suppressing the skin.

Why treatments work better in combination

Vitiligo often responds best when treatments are paired rather than used alone, and the reason lies in how repigmentation actually happens. An anti-inflammatory cream calms the autoimmune attack that is destroying melanocytes, while light therapy stimulates the surviving pigment cells — many of which hide in the base of hair follicles — to multiply and migrate out into the white patch. One treatment protects; the other rebuilds.

That is why combining phototherapy and cream for vitiligo is a common strategy: studies and everyday practice both suggest the pair tends to outperform either piece by itself, particularly on responsive areas like the face. A clinician sequences and spaces them to avoid irritation, since light and some creams can each sensitize the skin.

The combination also explains why hairy areas repigment more readily than smooth ones. The follicles act as reservoirs of pigment cells; skin with few follicles has fewer melanocytes to recruit, no matter how good the treatment. Reading the skin this way makes the uneven, dotted pattern of returning color easier to understand — and easier to stick with.

How response varies by body site

Where the vitiligo sits matters nearly as much as which treatment is used. The face and neck tend to respond best and fastest, the trunk and limbs do moderately well, and the hands, feet, fingertips, wrists, ankles, and skin over bony points are the most stubborn. This is not a matter of effort — it is anatomy.

The hardest areas share a feature: they have few hair follicles, and follicles are where the reservoir of pigment cells lives. So-called acral vitiligo, on the hands and feet, resists treatment for exactly this reason, and it is the site clinicians are most cautious about promising results for. Lips and fingertips fall into the same difficult category.

Knowing the geography up front changes how success is measured. Full repigmentation of a cheek is a reasonable hope; full repigmentation of a fingertip is not, and a plan that treats those two the same sets someone up for disappointment. For the most resistant sites, combining therapies and simple persistence over a long horizon tend to matter more than switching from one option to the next. Matching expectations to the map of the body is part of an honest treatment conversation.

What honest expectations look like

Repigmentation is real, but it is gradual, partial, and uneven, and setting that expectation is the difference between sticking with treatment and abandoning it too soon. Color usually returns not as a wave washing back over a patch but as tiny dots of pigment around hair follicles that slowly enlarge and merge, so early progress can look speckled and unimpressive before it fills in.

The timeline is measured in months, not weeks. Narrowband UVB, for instance, shows its benefit building over a sustained course of regular sessions, and stopping early is one of the most common reasons people conclude that nothing worked 2. Some areas repigment fully, others only partly, and a few not at all — which is why treatment is reviewed at planned checkpoints and adjusted rather than judged on a single glance. Understanding what vitiligo treatment can honestly return, area by area, keeps the effort pointed at what is achievable. Progress on the face can be encouraging within a few months, while stubborn sites may need a year or more of steady effort before a fair verdict.

The overarching truth from the institutions that study it is steady: there is no cure, but the condition can be stabilized and, in many people and many locations, meaningfully repigmented 1. That is a hopeful message and an honest one at the same time, which is exactly the register this deserves.

When repigmentation isn't the goal: stabilizing, camouflage, and surgery

Not everyone's aim is to chase pigment back into every patch, and the alternatives are legitimate choices rather than consolation prizes. When vitiligo is spreading quickly, the first priority is usually to stop it — clinicians may use a short course of oral steroids or other measures to halt the advance before turning to repigmentation. Stabilizing an active case can be as important as any cream. Momentum matters here: a case caught while it is still spreading is easier to stabilize than one left to advance for months.

For stable patches that have resisted creams and light, surgical techniques exist that move pigment cells from healthy skin into the white areas — grafting approaches offered at specialized centers for carefully selected, non-spreading vitiligo. They are not a first step, but they are a real option when the standard ladder has been exhausted.

Camouflage is the third path, and it is a valid one. Cosmetic cover products and self-tanners containing dihydroxyacetone can even out appearance without any medical risk, and diligent sun protection does double duty: it shields depigmented patches, which sunburn easily because they have lost their natural pigment defense, and it keeps the surrounding normal skin from tanning darker and deepening the contrast. Choosing camouflage over treatment, or alongside it, is a personal decision, not a failure of one.

Getting started, and the part that isn't about skin

Because every effective vitiligo treatment rewards consistency, it helps to begin with a clinician who will set a clear plan and an honest checkpoint — often several months out — to judge whether it is working before changing course. Insurance coverage and access to phototherapy or newer creams vary, so it is reasonable to ask about that early, along with what a realistic result would look like for your particular pattern and sites.

The part that gets least airtime is the emotional one. Vitiligo poses no threat to physical health and is not contagious, but its visibility can carry a real psychological weight, affecting confidence and mood in ways that have nothing to do with vanity. Good care takes that seriously, and support for it — from a clinician, a community, or a mental-health professional — belongs in the plan rather than outside it.

Vitiligo is also an autoimmune condition, and it sometimes keeps company with others, such as thyroid disease. That is another reason a considered evaluation is worth more than a rushed one: the goal is not only to treat the patches, but to understand the whole picture they sit in.

Common questions

There is no cure, but there are effective treatments. The realistic goals are to stabilize the condition so new patches stop forming and to repigment the white areas, which is achievable to varying degrees depending on the site and the person. Institutions that study vitiligo describe it this way: no cure, but the condition can be stabilized and, in many cases, meaningfully repigmented.

Months, not weeks. Color typically returns slowly, first as small dots around hair follicles that gradually merge, and treatments like narrowband UVB show their benefit building over a sustained course. The face responds fastest. Because progress is gradual, treatment is judged at planned checkpoints rather than day to day, and stopping too early is a common reason people conclude nothing worked.

In large phase 3 trials of nonsegmental vitiligo in people aged 12 and older, topical ruxolitinib — a JAK-inhibitor cream — produced significantly more facial and overall repigmentation than an inactive vehicle cream. It works best on the face and, like other options, gradually over months. Whether it fits a given person, and how it pairs with light therapy, is a clinician's call.

The hands, feet, and fingertips are the hardest areas because they have few hair follicles, and follicles are where the reservoir of pigment cells that repopulate a patch lives. This so-called acral vitiligo resists every treatment for the same anatomical reason. Combination therapy and persistence help, but full repigmentation of these sites is not a realistic promise.

Vitiligo is not contagious and poses no threat to physical health, but it is not entirely without consequence. Depigmented patches sunburn easily because they have lost their natural pigment protection, so sun care matters. And its visibility can carry a genuine emotional weight, which good care treats as part of the condition rather than a side issue.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Vitiligo: what to watch and when to get seen

  • —White patches spreading quickly over weeks — rapid spread is worth prompt review, since stabilizing it early is a specific treatment goal
  • —A depigmented patch that becomes painful, blistered, or badly sunburned, because it lacks its natural sun protection
  • —A pigmented spot or mole that is changing, growing, or bleeding — a separate concern from vitiligo that needs its own evaluation
  • —Vitiligo alongside new symptoms like unusual fatigue, weight change, or neck swelling — other autoimmune conditions can travel with it

Vitiligo itself is not a medical emergency, but if its emotional weight ever becomes overwhelming, the 988 Suicide and Crisis Lifeline is reachable any time by call or text.

This article is general health information, not a diagnosis or a treatment plan. Which vitiligo treatments fit, in what order, and how to judge them belongs with a clinician who can examine your skin, weigh how active the condition is, and tailor a plan to your pattern and sites.

References

  1. 1.National Institute of Arthritis and Musculoskeletal and Skin Diseases (2024). Vitiligo. NIH / NIAMS. link ✓That vitiligo is a chronic autoimmune disorder in which melanocytes are destroyed, causing depigmented milky-white patches, can begin at any age, and has no cure but treatments that can stabilize the condition and repigment the skin.
  2. 2.Bae JM, Jung HM, Hong BY, et al. (2017). Phototherapy for Vitiligo: A Systematic Review and Meta-analysis. JAMA Dermatology. link ✓That narrowband UVB phototherapy produces meaningful repigmentation in vitiligo, with the response increasing over months of continued treatment.
  3. 3.Rosmarin D, Passeron T, Pandya AG, et al. (2022). Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo. New England Journal of Medicine. doi:10.1056/NEJMoa2118828 ✓That topical ruxolitinib (a JAK1/2 inhibitor) cream produced significantly greater facial and total-body repigmentation than vehicle in nonsegmental vitiligo in patients aged 12 and older, in the TRuE-V1 and TRuE-V2 phase 3 trials.

3 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy

← Back to the health library